Phase II study of capecitabine plus oxaliplatin in patients with gastric cancer resistant/intolerable to CDDP (OGSG1403)

Hirokazu TaniguchiNaotoshi Sugimoto, Junji Kawada, Shugo Ueda, Kohei Murakami, Kazuhiro Nishikawa, Yukinori Kurokawa, Kazumasa Fujitani, Hisato Kawakami, Daisuke Sakai, Toshio Shimokawa, Taroh SatohOsaka Gastrointestinal Study Group (OGSG)　第17回日本臨床腫瘍学会学術集会　2019.7.18-20 京都

Warning: Trying to access array offset on false in /home/grwdev/grwdev.works/public_html/ogsg2026.grwdev.works/wp/wp-content/themes/OGSG/single.php on line 62